ARTICLE | Company News
Juvaris, Valentis deal
June 14, 2004 7:00 AM UTC
The companies expanded a 2003 deal under which Juvaris non-exclusively licensed VLTS's plasmid backbone and cationic lipid delivery technologies to develop and commercialize therapeutic vaccines (see ...